Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis - Hilberg - 2012 - The Clinical Respiratory Journal - Wiley Online Library
The multifaceted role of pirfenidone and its novel targets | Fibrogenesis & Tissue Repair | Full Text
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evid | CE
吡非尼酮 | New Drug Approvals
Pirfenidone: A novel hypothetical treatment for COVID-19. - Abstract - Europe PMC
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy | Semantic Scholar
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Pirfenidone targets. Different targets in vivo and in vitro for PFD... | Download Scientific Diagram
Treatment for IPF: The changing landscape - ppt download
Reversion of in vivo fibrogenesis by novel chromone scaffolds - eBioMedicine
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
Biomedicines | Free Full-Text | Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease | HTML
Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model - ScienceDirect
Antifibrotic activities of pirfenidone in animal models | European Respiratory Society
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation | Oncotarget
Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease - Cellular and Molecular Gastroenterology and Hepatology
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 | SpringerLink
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence - ScienceDirect
A NEW ERA in IPF: Trials and Treatments - ppt download
Proposed mechanism of action of nintedanib in idiopathic pulmonary... | Download Scientific Diagram
Treatment | Idiopathic Pulmonary Fibrosis | Medthority.com
Key interactors in the predicted mechanism of action of pirfenidone and... | Download Scientific Diagram
Potential mechanisms for the suppression of fibrogenesis by... | Download Scientific Diagram
Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma
Key interactors in the predicted mechanism of action of pirfenidone and... | Download Scientific Diagram
August | 2017 | SugarCone Biotech
